Doctors targeted by marketing schemes tend to
prescribe
more, newer, and pricier drugs regardless of the drug's efficacy compared
to less expensive medications - sometimes with deadly consequences. As
The Prescription Project
reports,
Merck spent $209 million marketing the painkiller Vioxx, driving
up utilization before the medical community had a full understanding of
the drug's side effects. The premature
and rapid adoption of Vioxx resulted in up to 139,000 heart attacks, 40%
of which were fatal.
States can establish "Academic
Detailing" programs to save lives and reduce costs. Academic
detailing programs send highly-educated medical professionals to doctors'
offices with scientific and unbiased information about which drugs are right
for a given situation, countering the industry's direct-to-physician marketing
and sales. Studies have found that
for every dollar spent on "academic detailing," two dollars are
saved.
Pennsylvania's Independent Drug Information Service program
is a partnership between the state and Harvard Medical
School. Elsewhere, Maine, New Hampshire, and Vermont
are creating a multi-state
academic detailing collaborative with support from Prescription Policy Choices. In addition to Vermont's
existing program, Maine enacted Public
Law Chapter 327 in 2007 and New
Hampshire enacted HB 1513
in 2008 creating academic detailing programs. Mississippi also
established a program for physicians participating in Medicaid.
Resources:
The Prescription Project -
Academic
Detailing: Evidence-Based Prescribing Information
The Prescription Project -
Cost-Effectiveness
of Prescriber Education (Academic Detailing) Programs